^
Association details:
Biomarker:APC mutation
Cancer:Colon Cancer
Drug Class:Immunotherapy
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Title:

APC mutation correlated with poor response of immunotherapy in colon cancer

Published date:
03/28/2023
Excerpt:
The survival analysis demonstrated that APC mutation was correlated with a worse immunotherapy outcome….In conclusion, we demonstrated that the colon cancer patients with APC mutations were associated with poor response of immunotherapy.
DOI:
10.1186/s12876-023-02725-3